Chinese Academy of Medical Sciences

🇨🇳China
Ownership
Private, Subsidiary
Established
2004-07-08
Employees
-
Market Cap
-
Website
http://www.pinganzhengxing.com

Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer

First Posted Date
2011-12-15
Last Posted Date
2013-03-15
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
30
Registration Number
NCT01492543
Locations
🇨🇳

Beijing Chao-yang Hospital, Beijing, Beijing, China

🇨🇳

Chinese PLA General Hospital, Beijing, Beijing, China

🇨🇳

China-Japan Friendship Hospital, Beijing, Beijing, China

and more 4 locations

Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer

Phase 2
Conditions
Interventions
First Posted Date
2011-12-15
Last Posted Date
2013-03-15
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
100
Registration Number
NCT01492556
Locations
🇨🇳

Beijing Hospital of the Ministry of Health, Beijing, Beijing, China

🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

🇨🇳

Peking University Cancer Hospital, Beijing, Beijing, China

and more 11 locations

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-11-02
Last Posted Date
2021-02-04
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
46
Registration Number
NCT01463605
Locations
🇨🇳

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China

Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-10-20
Last Posted Date
2017-07-05
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
76
Registration Number
NCT01456156
Locations
🇨🇳

Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-09-30
Last Posted Date
2014-05-06
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
50
Registration Number
NCT01444521
Locations
🇨🇳

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China

A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin

First Posted Date
2011-09-30
Last Posted Date
2014-05-06
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
92
Registration Number
NCT01444547
Locations
🇨🇳

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

Phase 2
Conditions
Interventions
First Posted Date
2011-09-09
Last Posted Date
2013-03-13
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
160
Registration Number
NCT01431053
Locations
🇨🇳

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China

Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery

Phase 3
Completed
Conditions
Interventions
First Posted Date
2011-08-10
Last Posted Date
2018-10-11
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
720
Registration Number
NCT01413269
Locations
🇨🇳

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China

🇨🇳

Beijing hospital, Beijing, Beijing, China

🇨🇳

Zhongshan Hospital Fudan University, Shanghai, Shanghai, China

and more 1 locations

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

First Posted Date
2011-06-22
Last Posted Date
2011-12-28
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
100
Registration Number
NCT01378533
Locations
🇨🇳

Cancer institute and hospital Chinese academy of medical sciences, Beijing, Beijing, China

© Copyright 2024. All Rights Reserved by MedPath